GSK and eosinophil research: the pharmaphorum podcastGlaxoSmithKline’s Nucala (mepolizumab) last month became the first and only biologic treatment approved in the US for Hypereosinophilic Share XGSK and eosinophil research: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/gsk-eosinophil-research/
